References
- ACPM (American College of Preventive Medicine). (2011). Use, Abuse, Misuse & Disposal of Prescription Pain Medication Clinical Reference. Retrieved December 2, 2014, from http://www.acpm.org/?UseAbuseRxClinRef#Terminology
- Alcohol_and_other_Drugs_Council_of_Australia. (2003). Misuse of Prescription Drugs. Retrieved from http://www.ibrarian.net/navon/paper/Alcohol_and_other_Drugs_Council_of_Australia_Sept.pdf?paperid=10219950
- Ashton, H. (2005). The diagnosis and management of benzodiazepine dependence. Current Opinion in Psychiatry, 18(3), 249–255. doi:10.1097/01.yco.0000165594.60434.84.
- Boyd, C. J., & McCabe, S. E. (2008). Coming to terms with the nonmedical use of prescription medications. Substance Abuse Treatment, Prevention, and Policy, 3, 22. doi:10.1186/1747-597x-3-22.
- Casati, A., Sedefov, R., & Pfeiffer-Gerschel, T. (2012). Misuse of medicines in the European Union: a systematic review of the literature. European Addiction Research, 18(5), 228–245. doi:10.1159/000337028.
- CSEW_2011_12. (2012). Drug Misuse Declared: Findings From the 2011/12 Crime Survey for England and Wales. Retrieved from https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/147938/drugs-misuse-dec-1112-pdf.pdf
- CSEW_2012_13. (2013). Drug Misuse: Findings from the 2012/13 Crime Survey for England and Wales. Retrieved from https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/225122/Drugs_Misuse201213.pdf
- DAWN. (2013). Drug Abuse Warning Network Methodology Report, 2011 Update. Retrieved from http://archive.samhsa.gov/data/2k13/DAWN2k11ED/rpts/DAWN2k11-Methods-Report.htm
- EMCDDA. (2010). EMCDDA–Europol 2010 Annual Report on the Implementation of Council Decision 2005/387/JHA. Retrieved from http://www.emcdda.europa.eu/attachements.cfm/att_132857_EN_EMCDDA-Europol%20Annual%20Report%202010A.pdf
- Epidemic. (2011). Epidemic: Responding to America’s Prescription Drug Abuse Crisis (Executive Office of The President of The United States). Retrieved from http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/rx_abuse_plan.pdf
- FDA. (2010). Combating Misuse and Abuse of Prescription Drugs. Retrieved from http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM220434.pdf
- Fischer, B., & Argento, E. (2012). Prescription opioid related misuse, harms, diversion and interventions in Canada: A review. Pain Physician, 15 (3 Suppl), Es191–203.
- Fischer, B., Bibby, M., & Bouchard, M. (2010). The global diversion of pharmaceutical drugs non-medical use and diversion of psychotropic prescription drugs in North America: A review of sourcing routes and control measures. Addiction, 105(12), 2062–2070. doi:10.1111/j.1360-0443.2010.03092.x.
- Global_Drug_Survey. (2012). The Guardian/Mixmag Global Drug Survey. Retrieved December 2, 2014, from http://www.theguardian.com/society/datablog/2012/mar/15/global-drug-survey-us-uk#data
- Hernandez, S. H., & Nelson, L. S. (2010). Prescription drug abuse: Insight into the epidemic. Clinical Pharmacology & Therapeutics, 88(3), 307–317. doi:10.1038/clpt.2010.154.
- Holm, K. J., & Goa, K. L. (2000). Zolpidem: An update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs, 59(4), 865–889.
- Inciardi, J. A., Surratt, H. L., Cicero, T. J., Kurtz, S. P., Martin, S. S., & Parrino, M. W. (2009). The “black box” of prescription drug diversion. Journal of Addictive Diseases, 28(4), 332–347. doi:10.1080/10550880903182986.
- Inciardi, J. A., Surratt, H. L., Kurtz, S. P., & Cicero, T. J. (2007). Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Medicine, 8(2), 171–183. doi:10.1111/j.1526-4637.2006.00255.x.
- Johansson, B. A., Berglund, M., Hanson, M., Pohlen, C., & Persson, I. (2003). Dependence on legal psychotropic drugs among alcoholics. Alcohol Alcohol, 38(6), 613–618.
- Kapil, V., Green, J. L., Le Lait, C., Wood, D. M., & Dargan, P. I. (2014a). Misuse of benzodiazepines and Z-drugs in the UK. The British Journal of Psychiatry, 205(5), 407–408. doi:10.1192/bjp.bp.114.149252.
- Kapil, V., Green, J. L., Le Lait, M. C., Wood, D. M., & Dargan, P. I. (2014b). Misuse of the gamma-aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK. The British Journal of Clinical Pharmacology, 78(1), 190–191.
- Kurtz, S. P., Inciardi, J. A., & Pujals, E. (2009). Criminal activity among young adults in the club scene. Law Enforcement Executive Forum, 9(2), 47–59.
- Kurtz, S. P., Inciardi, J. A., Surratt, H. L., & Cottler, L. (2005). Prescription drug abuse among ecstasy users in Miami. Journal of Addictive Diseases, 24(4), 1–16.
- Kurtz, S. P., Surratt, H. L., Levi-Minzi, M. A., & Mooss, A. (2011). Benzodiazepine dependence among multidrug users in the club scene. Drug and Alcohol Dependence, 119(1–2), 99–105. doi:10.1016/j.drugalcdep.2011.05.036.
- McCabe, S. E., & Boyd, C. J. (2005). Sources of prescription drugs for illicit use. Addictive Behaviors, 30(7), 1342–1350. doi:10.1016/j.addbeh.2005.01.012.
- Measham, F., & Moore, K. (2009). Repertoires of distinction: Exploring patterns of weekend polydrug use within local leisure scenes across the English night time economy. Criminology and Criminal Justice, 9(4), 437–464. doi:10.1177/1748895809343406.
- Measham, F., Moore, K., & Østergaard, J. (2011a). Mephedrone, “bubble” and unidentified white powders: The contested identities of synthetic “legal highs”. Drugs and Alcohol Today, 11(3), 137–146. doi:10.1108/17459261111186467.
- Measham, F., Wood, D. M., Dargan, P. I., & Moore, K. (2011b). The rise in legal highs: Prevalence and patterns in the use of illegal drugs and first- and second-generation “legal highs” in South London gay dance clubs. Journal of Substance Use, 16(4), 263–272. doi:10.3109/14659891.2011.594704.
- National_Drug_Strategy. (2015). National Pharmaceutical Drug Misuse Framework for Action (2012–2015) . Retrieved from http://nceta.flinders.edu.au/files/7913/9752/6856/EN543.pdf
- NIDA. (2011). National Institute of Drug Abuse: Prescription Drugs: Abuse and Addiction. Retrieved December 2, 2014, from http://www.drugabuse.gov/sites/default/files/rrprescription.pdf
- NIH_Community_Epidemiology_Work_Group. (2013). Epidemiologic Trends in Drug Abuse. Retrieved from http://www.drugabuse.gov/sites/default/files/files/AdvanceReport2013.pdf
- NIH_Drug_Abuse. (2014). Drug Facts: Prescription and Over-the-Counter Medications. Retrieved from http://www.drugabuse.gov/sites/default/files/drugfacts_rx_12_2014.pdf
- SAMHSA. (2013). Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. Retrieved from http://media.samhsa.gov/data/NSDUH/2012SummNatFindDetTables/NationalFindings/NSDUHresults2012.pdf
- Victorri-Vigneau, C., Dailly, E., Veyrac, G., & Jolliet, P. (2007). Evidence of zolpidem abuse and dependence: Results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. British Journal of Clinical Pharmacology, 64(2), 198–209. doi:10.1111/j.1365-2125.2007.02861.x.
- Wood, D. M., Brailsford, A. D., & Dargan, P. I. (2011). Acute toxicity and withdrawal syndromes related to gamma-hydroxybutyrate (GHB) and its analogues gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD). Drug Testing and Analysis, 3(7–8), 417–425. doi:10.1002/dta.292.
- Wood, D. M., Measham, F., & Dargan, P. I. (2012). “Our favourite drug”: Prevalence of use and preference for mephedrone in the London night-time economy 1 year after control. Journal of Substance Use, 17(2), 91–97. doi:10.3109/14659891.2012.661025.
- Yokell, M. A., Delgado, M. K., Zaller, N. D., Wang, N. E., McGowan, S. K., & Green, T. C. (2014). Presentation of prescription and nonprescription opioid overdoses to US emergency departments. JAMA Internal Medicine. doi:10.1001/jamainternmed.2014.5413.